Osaühing Pharmax Group

14994990

General info

Name

Osaühing Pharmax Group

Registry code

14994990

VAT number

EE102300064

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

22.06.2020 (4)

Financial year

01.01-31.12

Capital

3 000.00 €

Activity

46181 - Agents specialised in the sale of other particular products

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

MHM Invest OÜ

12516938

33% - 1 000.00 EUR - - Founder

Wismo OÜ

14131349

33% - 1 000.00 EUR - - Founder

OÜ Netdoktor

10620583

33% - 1 000.00 EUR - -

Maido Mölder

06.02.1982 (42)

- Board member Indirect ownership

Martin Henning

28.08.1975 (49)

- Board member Indirect ownership

Rasmus Kuklane

04.10.1983 (41)

- Board member -

OÜ Hagarex

10329273

- - - Founder

Financial info

2020
15.07.2021
2021
30.12.2022
2022
15.10.2023
Total Revenue - 420 891 € 409 252 €
Net profit (loss) for the period -8 110 € 376 679 € 272 798 €
Profit Margin - 89% 67%
Current Assets 4 063 € 379 546 € 388 133 €
Fixed Assets - - -
Total Assets 4 063 € 379 546 € 388 133 €
Current Liabilities 9 173 € 7 977 € 43 766 €
Non Current Liabilities - - -
Total Liabilities - - -
Share Capital - - -
Equity -5 110 € 371 569 € 344 367 €
Employees 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 104 164.51 € 45 668.01 € 1 102.44 € 1
2023 Q4 169 245.75 € 1 016.85 € 1 102.44 € 1
2023 Q3 - 29 795.92 € 1 102.44 € 1
2023 Q2 78 810.21 € 1 016.85 € 1 102.44 € 1
2023 Q1 119 048 € 38 516.85 € 1 102.44 € 1
2022 Q4 69 547.21 € 1 016.85 € 1 102.44 € 1
2022 Q3 86 121.77 € 1 016.85 € 1 102.44 € 1
2022 Q2 134 534.74 € 38 516.85 € 1 102.44 € 1
2022 Q1 116 515.66 € 1 016.85 € 1 102.44 € 1
2021 Q4 69 305.53 € 1 016.85 € 1 102.44 € 1
2021 Q3 73 466.3 € 338.95 € 367.48 € 1
2021 Q2 49 488.42 € - - -
2021 Q1 112 114.79 € - - -
2020 Q4 - - - -